Background:

The modality of intraoperative neuromonitoring (IONM) in lateral approaches for interbody fusion varies. We aim to examine the types of neuromonitoring utilized in lateral interbody fusion (LIF) and associated neurologic complications.

Methods:

A systematic review was performed using the PRISMA guidelines. PubMed and Embase databases were searched from inception to July 2022 for articles examining lumbar interbody fusion (LIF) of lateral lumbar interbody fusion (LLIF) or oblique lateral interbody fusion (OLIF) with IONM modalities. LIF with/without IONM were included. Articles without original patient data, case reports with fewer than 2 patients, non-English articles, non-lateral procedures, and non-human studies were excluded. The ROBINS-I tool was used to assess for bias.

Results:

A total of 34 studies were included. Twenty LLIF articles had IONM, while one LLIF article did not have IONM. Three OLIF articles specified IONM, while 6 OLIF articles did not have IONM. Two articles had patients undergoing either LLIF or OLIF. For LLIF, overall neurologic complications, motor weakness, and sensory deficits were 19.8%, 7.6%, and 10.6%, respectively. OLIF overall neurologic complications, motor weakness, and sensory deficits were 5.9%, 2.9%, and 3.2%, respectively. Neurologic outcomes with IONM were not superior compared to without IONM in either LLIF or OLIF.

Conclusion:

Neurologic complication rates in LLIF remain high despite utilization of IONM. Utilization of IONM did not benefit neurologic outcomes. More prospective studies with different IONM modalities and without IONM are needed before determining specific benefits or shortcomings of each IONM modality.